For the quarter, about a third of the schemes managed to beat the benchmark index (up 19.8 per cent for the three months ended June 30), with average returns of 17 per cent for the large-cap, 17.4 per cent for multi-cap, 20.2 per cent for mid-cap, and 24.1 per cent for small-cap categories. The top performers include Nine Rivers Capital Aurum Small Cap Opportunities (40.2 per cent) and Right Horizons Minerva India Under-Served (28 per cent).
For a one-year period, 70 per cent of the PMS schemes have beaten the Nifty, which slid by 12.6 per cent. Average returns of all the categories ranged between -5.9 per cent and -13.3 per cent. The best performers include Kotak Pharma (36.6 per cent), Valcreate Inv. Managers Lifesciences & Special Opp. (36.1 per cent) and Wize Market Analytics Capital Mind - Momentum (19.8 per cent).